Coexpression of Activated c-Met and Death Receptor 5 Predicts Better Survival in Colorectal Carcinoma

Dysregulated overexpression of hepatocyte growth factor and its receptor, c-Met, has been reported in various cancers, but its role in colorectal carcinoma (CRC) has not been elucidated. Therefore, we investigated the role of phosphorylated Met (p-Met) in Middle Eastern CRC patient samples and cell...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Uddin, Shahab, Hussain, Azhar R., Ahmed, Maqbool, Al-Sanea, Nasser, Abduljabbar, Alaa, Ashari, Luai H., Alhomoud, Samar, Al-Dayel, Fouad, Bavi, Prashant, Al-Kuraya, Khawla S.
Format: Artigo
Idioma:Inglês
Publicat: American Society for Investigative Pathology 2011
Matèries:
Regular Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3260832/
https://ncbi.nlm.nih.gov/pubmed/21978492
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ajpath.2011.08.007
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars